NVS | tickerfilter.com

Fundamental analysis

51%

Profitability 40%

Dept financing 42%

Liquidity 43%

Performance 67%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

1.83%

1 Month

-0.38%

3 Months

10.11%

6 Months

-3.02%

1 Year

15.50%

2 Year

9.33%

Key data

Stock price

$112.14

P/E Ratio

16.66

DAY RANGE

$110.98 - $112.26

EPS

$5.76

52 WEEK RANGE

$96.06 - $120.92

52 WEEK CHANGE

$15.50

MARKET CAP

198.905 B

YIELD

3.88%

SHARES OUTSTANDING

2.190 B

DIVIDEND

$3.8695

EX-DIVIDEND DATE

03-12-2025

NEXT EARNINGS DATE

04-29-2025

BETA

0.27

PUBLIC FLOAT

AVERAGE 10 VOLUME

$1,861,062

AVERAGE 30 VOLUME

$2,594,798

Company detail

CEO: Vasant Narasimhan
Region: US
Website: novartis.com
Employees: 101,700
IPO year: 1996

Issue type: American Depository Receipt (ADR’s)
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Novartis AG researches, develops, manufactures, and markets healthcare products. The company operates through two segments, Innovative Medicines and Sandoz. Sandoz provides finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals.

NVS - NOVARTIS AG